Abstract:Liling Chen, 1 Cunqing Zheng, 1 Honglin Luan, 2 Xinyuan Chen 3 1 Department of Clinical Laboratory, Wenzhou Seventh People's Hospital, Wenzhou, Zhejiang Province, People's Republic of China; 2 Department of Psychiatry, Wenzhou Seventh People's Hospital, Wenzhou, Zhejiang Province, People's Republic of China; 3 Department of Clinical Laboratory, Wenzhou Central Hospital, Wenzhou, Zhejiang Province, People's Republic of China Correspondence: Xinyuan Chen, Department of Clinical Laboratory, Wenzhou Central Hospital, Bailidonglu Street, Lucheng District, Wenzhou, 325000, People's Republic of China, Tel +8615858805715, Fax +86057788070190, Email Purpose: This study aimed to assess High-density Lipoprotein (HDL)-based Inflammatory Indices and lipid profile changes in antipsychotic-naive first-episode schizophrenia (AN-FES) patients, chronic schizophrenia (CS) patients, and explore the clinical and predictive value of these parameters for schizophrenia. Patients and Methods: The study cohort included 52 AN-FES patients, 46 CS patients, and 52 healthy controls (HCs), with an average age of 24 years. Upon admission, patients underwent complete blood count and lipid profile analyses. Various ratios were calculated, including neutrophil-to-HDL (NHR), monocyte-to-HDL (MHR), lymphocyte-to-HDL (LHR), and platelet-to-HDL (PHR), as well as lipid ratios like triglycerides/HDL, non-HDL/HDL, total cholesterol/HDL, and low-density lipoprotein/HDL. For the AN-FES group, these evaluations were repeated after two months of treatment with atypical antipsychotics. Statistical analyses included correlation analysis, Receiver Operating Characteristic (ROC) curve analysis, and univariate and multivariate regression. Results: Compared to HCs, CS patients exhibited significantly higher MHR and NHR values, while AN-FES patients showed elevated levels of PHR, MHR, and NHR. No significant differences were observed in LHR or lipid ratios across the three groups. In the AN-FES cohort, MHR correlated positively with neutrophil counts, and NHR with monocyte counts. Additionally, white blood cell counts were positively associated with both MHR and NHR. Following treatment, NHR levels decreased, whereas TG/HDL ratios increased, with MHR and PHR remaining elevated. ROC analysis highlighted NHR as the most diagnostically valuable parameter (AUC = 0.799), with 86.5% specificity at an optimal cutoff of 3.534, outperforming MHR and PHR. Regression analyses recognized NHR (OR=2.225) as an independent risk factor for schizophrenia, even after adjusting for confounders. Conclusion: HDL-based inflammatory indices, particularly NHR, may serve as valuable diagnostic and prognostic markers in young adults with schizophrenia, even though significant alterations in lipid ratios were not observed in this demographic. Keywords: neutrophil-to-HDL ratio, NHR, monocyte-to-HDL ratio, MHR, platelet-to-HDL ratio, PHR, lipid ratios, schizophrenia, inflammatory indices Schizophrenia (SCZ) is a severe mental disorder that affects millions of people globally. It is characterized by cognitive disturbances, perceptual anomalies, and emotional blunting. Despite extensive research, the etiology of SCZ remains unclear, involving complex interactions between immune, environmental, and genetic factors. 1,2 Recent studies indicate that inflammation and immune dysfunction, both within the central nervous system and peripheral immune responses, 3,4 along with oxidative stress, play significant roles in the pathophysiology of SCZ. 5,6 Individuals with chronic schizophrenia (CS) or those experiencing their first episode of schizophrenia may exhibit systemic inflammation and disruptions in lipid metabolism. 7–11 Abnormal lipid metabolism may contribute to inflammation in various diseases, 12 highlighting the importance of investigating the relationship between inflammatory and metabolic pathways in SCZ. 13–15 High-density lipoprotein cholesterol (HDL) is a crucial component of the blood lipid profile recognized for its anti-thrombotic, anti-inflammatory, and antioxidant properties, as well as its regulation of activated neutrophil functions. 16–18 Decreased HDL levels were shown to be related to inflammation. 19 Inflammatory responses can cause fluctuations in the levels of neutrophils, monocytes, lymphocytes, and platelets, all of which are easily measured through a complete blood count. 20 Consequently, combined markers derived from peripheral blood cell measures and biochemical assays, such as the neutrophil-to-HDL ratio (NHR), lymphocyte-to-HDL ratio (LHR), monocyte-to-HDL ratio (MHR), and platelet-to-HDL ratio (PHR), are under scrutiny -Abstract Truncated-

Role of HOMA-IR and IL-6 As Screening Markers for the Metabolic Syndrome in Patients with Chronic Schizophrenia: a Psychiatric Hospital-Based Cross-Sectional Study

Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics.

Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder

Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy

Comparative predictive efficacy of atherogenic indices on metabolic syndrome in patients with schizophrenia

Changes in Inflammatory Biomarkers in Patients with Schizophrenia: A 3-Year Retrospective Study

Cardiometabolic biomarkers and comorbid metabolic syndrome in schizophrenia: A cross-sectional study of long-term clozapine/olanzapine users

Correlation of Serum High-Sensitivity C-Reactive Protein, Homocysteine, and Macrophage Migration Inhibitory Factor Levels With Symptom Severity and Cognitive Function in Patients With Schizophrenia

The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia

Prevalence of metabolic syndrome and its related factors in schizophrenic inpatients

Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients

Investigation of metabolic syndrome in inpatients of chronic schizophrenia with long-term clozapine treatment

Clinical and Diagnostic Value of High-Density Lipoprotein-Based Inflammatory Indices and Lipid Ratios in Young Adults with Schizophrenia

Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia

The potential predictive value and relationship of blood-based inflammatory markers with the clinical symptoms of Han Chinese patients with first-episode adolescent-onset schizophrenia

Correlation Study of Metabolic Syndrome and Chronic Subclinical Inflammation

Association of Metabolic Syndrome with Serum Interleukin-10 and High Sensitive C Reactive Protein(hs-Crp)in Old Men

A related study of social functioning and quality of life in patients with schizophrenia with metabolic syndrome

Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study

Metabolic profiling for water-soluble metabolites in patients with schizophrenia and healthy controls in a Chinese population: A case-control study.

Ndt_a_218483 191..199